The primary objective of the study was met , demonstrating that etoricoxib 120mg qd was non-inferior to ibuprofen 600mg qid ; further , etoricoxib was statistically superior to ibuprofen 600mg qid according to the primary endpoint ( TOPAR6 ) and patient global assessments of study medication .